The biology of human natural killer-cell subsets

Robertson, 1990, Biology and clinical relevance of human natural killer cells, Blood, 76, 2421, 10.1182/blood.V76.12.2421.2421

Lanier, 1986, The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes, J. Immunol., 136, 4480, 10.4049/jimmunol.136.12.4480

Lanier, 1989, Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule, J. Exp. Med., 169, 2233, 10.1084/jem.169.6.2233

Nitta, 1989, Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural-killer–target-cell interaction, J. Exp. Med., 170, 1757, 10.1084/jem.170.5.1757

Suzuki, 1991, Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells, J. Exp. Med., 173, 1451, 10.1084/jem.173.6.1451

Andre, 2000, Modification of P-selectin glycoprotein ligand 1 with a natural-killer-cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin, Proc. Natl. Acad. Sci. U. S. A., 97, 3400, 10.1073/pnas.040569797

Voss, 1998, Participation of the CD94 receptor complex in costimulation of human natural killer cells, J. Immunol., 160, 1618, 10.4049/jimmunol.160.4.1618

Colonna, 1997, A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, J. Exp. Med., 186, 1809, 10.1084/jem.186.11.1809

Caligiuri, 1990, Functional consequences of interleukin-2 receptor expression on resting human lymphocytes. Identification of a novel natural-killer-cell subset with high-affinity receptors, J. Exp. Med., 171, 1509, 10.1084/jem.171.5.1509

Nagler, 1990, Constitutive expression of high-affinity interleukin-2 receptors on human CD16− natural killer cells in vivo, J. Exp. Med., 171, 1527, 10.1084/jem.171.5.1527

Voss, 1992, Characterization of the interleukin-2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2Rγ chain with the IL-2Rβ chain in functional intermediate-affinity IL-2R, J. Exp. Med., 176, 531, 10.1084/jem.176.2.531

Matos, 1993, Expression of a functional c-kit receptor on a subset of natural killer cells, J. Exp. Med., 178, 1079, 10.1084/jem.178.3.1079

Cooper, 2001, Interleukin-1β costimulates interferon-γ production by human natural killer cells, Eur. J. Immunol., 31, 792, 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U

Kunikata, 1998, Constitutive and induced IL-18 receptor expression by various peripheral-blood-cell subsets as determined by anti-hIL-18R monoclonal antibody, Cell. Immunol., 189, 135, 10.1006/cimm.1998.1376

Campbell, 2001, Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire, J. Immunol., 166, 6477, 10.4049/jimmunol.166.11.6477

Frey, 1998, Differential expression and function of L-selectin on CD56bright and CD56dim natural-killer-cell subsets, J. Immunol., 161, 400, 10.4049/jimmunol.161.1.400

Sedlmayr, 1996, Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural-killer-cell subpopulations, Int. Arch. Allergy Immunol., 110, 308, 10.1159/000237321

Lanier, 2000, Turning on natural killer cells, J. Exp. Med., 191, 1259, 10.1084/jem.191.8.1259

Moretta, 2001, Activating receptors and coreceptors involved in human natural-killer-cell-mediated cytolysis, Annu. Rev. Immunol., 19, 197, 10.1146/annurev.immunol.19.1.197

Lanier, 1998, NK cell receptors, Annu. Rev. Immunol., 16, 359, 10.1146/annurev.immunol.16.1.359

Bauer, 1999, Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA, Science, 285, 727, 10.1126/science.285.5428.727

Cosman, 2001, ULBPs, novel MHC-class-I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor, Immunity, 14, 123, 10.1016/S1074-7613(01)00095-4

Sivori, 2000, Involvement of natural cytotoxicity receptors in human natural-killer-cell-mediated lysis of neuroblastoma and glioblastoma cell lines, J. Neuroimmunol., 107, 220, 10.1016/S0165-5728(00)00221-6

Leibson, 1997, Signal transduction during natural-killer-cell activation: inside the mind of a killer, Immunity, 6, 655, 10.1016/S1074-7613(00)80441-0

Caligiuri, 1993, Selective modulation of human natural killer cells in vivo after prolonged infusion of low-dose recombinant interleukin-2, J. Clin. Invest., 91, 123, 10.1172/JCI116161

Baume, 1992, Differential responses to interleukin-2 define functionally distinct subsets of human natural killer cells, Eur. J. Immunol., 22, 1, 10.1002/eji.1830220102

Carson, 1994, The c-kit ligand suppresses apoptosis of human natural killer cells through the up-regulation of bcl-2, Proc. Natl. Acad. Sci. U. S. A., 91, 7553, 10.1073/pnas.91.16.7553

Carson, 1995, The functional characterization of interleukin-10 receptor expression on human natural killer cells, Blood, 85, 3577, 10.1182/blood.V85.12.3577.bloodjournal85123577

Wang, 2000, Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4, Blood, 95, 3183, 10.1182/blood.V95.10.3183

Carson, 1994, Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J. Exp. Med., 180, 1395, 10.1084/jem.180.4.1395

Fehniger, 1999, Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response, J. Immunol., 162, 4511, 10.4049/jimmunol.162.8.4511

Inngjerdingen, 2001, Expression and regulation of chemokine receptors in human natural killer cells, Blood, 97, 367, 10.1182/blood.V97.2.367

Campbell, 1998, Chemokines and the arrest of lymphocytes rolling under flow conditions, Science, 279, 381, 10.1126/science.279.5349.381

Carson, 1997, CD56bright natural-killer-cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand, Eur. J. Immunol., 27, 354, 10.1002/eji.1830270203

Smith, 1992, Interleukin-2, Curr. Opin. Immunol., 4, 271, 10.1016/0952-7915(92)90076-Q

Robertson, 1990, Human natural-killer-cell adhesion molecules. Differential expression after activation and participation in cytolysis, J. Immunol., 145, 3194, 10.4049/jimmunol.145.10.3194

Aguado, 1999, Functional expression of CD43 on human natural killer cells, J. Leukocyte Biol., 66, 923, 10.1002/jlb.66.6.923

Solomon, 1995, Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+CD3− lymphocytes (NK cells), Cell. Immunol., 165, 294, 10.1006/cimm.1995.1217

Lanier, 2001, On guard-activating NK cell receptors, Nat. Immunol., 2, 23, 10.1038/83130

Nagler, 1989, Comparative studies of human FcRIII-positive and -negative natural killer cells, J. Immunol., 143, 3183, 10.4049/jimmunol.143.10.3183

Robertson, 1992, Response of human natural killer (NK) cells to NK-cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF, J. Exp. Med., 175, 779, 10.1084/jem.175.3.779

Konjevic, 1995, Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural-killer-cell subsets and its induction by interleukin-2, Immunol. Invest., 24, 499, 10.3109/08820139509066846

Aste-Amezaga, 1994, Cooperation of natural-killer-cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells, Cell. Immunol., 156, 480, 10.1006/cimm.1994.1192

Cooper, 2001, Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset, Blood, 97, 3146, 10.1182/blood.V97.10.3146

Peritt, 1998, Differentiation of human NK cells into NK1 and NK2 subsets, J. Immunol., 161, 5821, 10.4049/jimmunol.161.11.5821

Biron, 1999, Natural killer cells in antiviral defense: function and regulation by innate cytokines, Annu. Rev. Immunol., 17, 189, 10.1146/annurev.immunol.17.1.189

Robertson, 1993, Costimulatory signals are required for optimal proliferation of human natural killer cells, J. Immunol., 150, 1705, 10.4049/jimmunol.150.5.1705

Mrozek, 1996, Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells, Blood, 87, 2632, 10.1182/blood.V87.7.2632.bloodjournal8772632

Williams, 1998, Natural-killer-cell differentiation: insights from knockout and transgenic mouse models and in vitro systems, Immunol. Rev., 165, 47, 10.1111/j.1600-065X.1998.tb01229.x

Kennedy, 2000, Reversible defects in natural killer and memory CD8 T-cell lineages in interleukin-15-deficient mice, J. Exp. Med., 191, 771, 10.1084/jem.191.5.771

Fehniger, 2001, Interleukin-15: biology and relevance to human disease, Blood, 97, 14, 10.1182/blood.V97.1.14

Yu, 1998, Flt3 ligand promotes the generation of a distinct CD34+ human natural-killer-cell progenitor that responds to interleukin-15, Blood, 92, 3647, 10.1182/blood.V92.10.3647

Bancroft, 1993, The role of natural killer cells in innate resistance to infection, Curr. Opin. Immunol., 5, 503, 10.1016/0952-7915(93)90030-V

Parrish-Novak, 2000, Interleukin-21 and its receptor are involved in NK-cell expansion and regulation of lymphocyte function, Nature, 408, 57, 10.1038/35040504

Miller, 2001, Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2, Blood, 98, 705, 10.1182/blood.V98.3.705

King, 1996, Functions of human decidual NK cells, Am. J. Reprod. Immunol., 35, 258, 10.1111/j.1600-0897.1996.tb00041.x

Borrego, 1999, NK phenotypic markers and IL-2 response in NK cells from elderly people, Exp. Gerontol., 34, 253, 10.1016/S0531-5565(98)00076-X

Gottschalk, 1990, Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients, Bone Marrow Transplant., 5, 259

Jacobs, 1992, CD16−CD56+ natural killer cells after bone-marrow transplantation, Blood, 79, 3239, 10.1182/blood.V79.12.3239.bloodjournal79123239

Ruggeri, 1999, Role of natural-killer-cell alloreactivity in HLA-mismatched hematopoietic stem-cell transplantation, Blood, 94, 333, 10.1182/blood.V94.1.333.413a31_333_339

Shah, 2000, Cytokine replacement in patients with HIV-1 non-Hodgkin's lymphoma: the rationale for low-dose interleukin-2 therapy, Cancer J. Sci. Am., 6, S45

Fehniger, 2000, Potential mechanisms of human natural-killer-cell expansion in vivo during low-dose IL-2 therapy, J. Clin. Invest., 106, 117, 10.1172/JCI6218

Houghton, 2000, Monoclonal antibody therapies – a ‘constant’ threat to cancer, Nat. Med., 6, 373, 10.1038/74621

Clynes, 2000, Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets, Nat. Med., 6, 443, 10.1038/74704

Fehniger, 2001, Ontogeny and expansion of human natural killer cells: clinical implications, Int. Rev. Immunol., 20, 503, 10.3109/08830180109054417